The long-term efficacy and safety of DPP-IV inhibitors monotherapy and in combination with metformin in 18,980 patients with type-2 diabetes mellitus--a meta-analysis.

Abstract

PURPOSE To assess the long-term efficacy and safety of DPP-IV inhibitors therapy versus comparators in patients with T2DM. METHODS A comprehensive search for randomized controlled trials (RCTs; ≥24 weeks) was performed. RCTs had to compare DPP-IV inhibitors therapy with placebo, metformin and sulphonylureas + metformin. Inverse variance mean difference… (More)
DOI: 10.1002/pds.3586

Topics

Cite this paper

@article{Liu2014TheLE, title={The long-term efficacy and safety of DPP-IV inhibitors monotherapy and in combination with metformin in 18,980 patients with type-2 diabetes mellitus--a meta-analysis.}, author={Xia Liu and Qian Xiao and Li Zhang and Qiao Yang and Xiaoyan Liu and Lingjie Xu and Wen Yue Cheng}, journal={Pharmacoepidemiology and drug safety}, year={2014}, volume={23 7}, pages={687-98} }